---
title: "Armata Pharmaceuticals signs $10 million loan from largest holder Innoviva"
url: "https://aibio.space/news/armata-pharmaceuticals-signs-10-million-loan-largest-holder-innoviva/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-03-12"
section: "Debt Financing"
tickers: "AMEX:ARMP, NASDAQ:INVA"
source: "https://www.sec.gov/Archives/edgar/data/921114/000110465925023015/tm258929d1_ex99-1.htm"
summary: "The secured term loan matures on March 12, 2026. Armata also pushed back the maturity of three earlier Innoviva credit agreements to the same date."
---

By the aibio.space news desk.

Sources

- [Armata Pharmaceuticals, Inc. 8-K (2025-03-12)](https://www.sec.gov/Archives/edgar/data/921114/000110465925023015/tm258929d1_ex99-1.htm)

[ARMP](https://aibio.space/companies/armata-pharmaceuticals/) [INVA](https://aibio.space/companies/innoviva/)

2025-03-12

# Armata Pharmaceuticals signs $10 million loan from largest holder Innoviva at 14.0%

Tickers [ARMP](https://aibio.space/companies/armata-pharmaceuticals/)[INVA](https://aibio.space/companies/innoviva/)

The secured term loan matures on March 12, 2026. Armata also pushed back the maturity of three earlier Innoviva credit agreements to the same date.

## Key facts

- **Companies**: Armata Pharmaceuticals, Inc. (AMEX: ARMP), Innoviva, Inc. (NASDAQ: INVA)

- **News type**: Debt Financing

- **Primary source**: [Armata Pharmaceuticals, Inc. 8-K (2025-03-12)](https://www.sec.gov/Archives/edgar/data/921114/000110465925023015/tm258929d1_ex99-1.htm)

*An empty boardroom with a long table. CC0, via rawpixel. The picture shows the field, not the companies named.*

Armata Pharmaceuticals, Inc. (NYSE American: [ARMP](https://aibio.space/companies/armata-pharmaceuticals/)) entered into a $10 million secured credit agreement with Innoviva Strategic Opportunities LLC, a subsidiary of Innoviva, Inc. (Nasdaq: [INVA](https://aibio.space/companies/innoviva/)), the company said in a [press release](https://www.sec.gov/Archives/edgar/data/921114/000110465925023015/tm258929d1_ex99-1.htm) dated March 12, 2025. Innoviva is Armata's largest shareholder.

The agreement provides a secured term loan facility of $10 million at an interest rate of 14.0% per annum, maturing on March 12, 2026. Armata expects gross proceeds of $10 million at closing, before transaction-related expenses.

The two companies also amended the three credit and security agreements they had signed earlier. Among other things, the amendments extend the maturity dates under those agreements to March 12, 2026.

Armata said the money will advance its lead candidates AP-PA02 and AP-SA02, which target Pseudomonas aeruginosa and Staphylococcus aureus infections.

Chief Executive Officer Dr. Deborah Birx said the financing will let Armata read out its Phase 1b/2a trial in acute Staphylococcus aureus bacteremia and prepare for an end-of-Phase 2 meeting with the FDA. She said, "We are continuing to pursue additional sources of funding, including non-dilutive sources, to support our late-stage clinical trials."

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

ARMP

Armata Pharmaceuticals, Inc.

AMEX · United States

Open the starter desk

INVA

Innoviva, Inc.

NASDAQ · United States

Open the starter desk

## More in Debt Financing

Debt Financing

### [Pelthos amends Horizon venture loan, funds Loans E to H and adds Loans I and J](https://aibio.space/news/pelthos-amends-horizon-venture-loan-funds-loans-e-h-adds-loans/)

Oct 30, 2026

Debt Financing

### [Repligen announces $1.0 billion private convertible notes transaction](https://aibio.space/news/repligen-announces-1-0-billion-private-convertible-notes-transaction/)

Oct 30, 2026

Debt Financing

### [FOXO to buy Ludwig Enterprises preferred stock with majority voting power](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/)

Oct 29, 2026

---
Source page: https://aibio.space/news/armata-pharmaceuticals-signs-10-million-loan-largest-holder-innoviva/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Armata Pharmaceuticals signs $10 million loan from largest holder Innoviva", 2025-03-12, https://aibio.space/news/armata-pharmaceuticals-signs-10-million-loan-largest-holder-innoviva/